Basal-like breast cancers are typically classified as triple-negative, reflecting lack expression of estrogen and progesterone receptors (ER−/PR−), and absence of HER2 gene amplification (HER2−) (40,41). This evidence concerns the gene ESR1 and breast carcinoma.